Indian market closed in the green for the second day in a row. The S&P BSE Sensex rose over 200 points while the Nifty50 closed just a shade below 19,600 levels. Sector-wise, buying was seen in healthcare, telecom, IT and realty stocks while selling was seen in utilities, power, and metals
Monarch initiated coverage on Landmark Cars with a target price of Rs 830. It is a standout entity for its uniqueness – the only listed auto dealer in India and that too focused on luxury vehicles.
Poly Medicure Share Price: Find the latest news on Poly Medicure Stock Price. Get all the information on Poly Medicure with historic price charts for NSE / BSE. Experts & Broker view also get the Poly Medicure Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.
Shares of Poly Medicure hit a new high of Rs 1,083.90 after rallying 9 per cent on the BSE in intra-day trade on Friday. The stock of the medical equipment company, which has zoomed 22 per cent in two trading days, surpassed its previous high of Rs 1,044 touched on Thursday. In the past three months, it has soared 113 per cent as compared to a 1.7 per cent decline in the S&P BSE Sensex. Meanwhile, ace investor Ashish Kacholia held 1.70 million equity shares or a 1.77 per cent stake in Poly Medicure at the end of the March 2021 quarter, as per the latest shareholding data. Kacholia had sold 50,000 equity shares during the January-March quarter. He held 1.75 million shares in the company as of December 2020 quarter, data shows.
Shares of Poly Medicure hit a new high of Rs 804 after rallying 11 per cent on the BSE in intra-day trade on Tuesday. With today’s gain, the stock of the medical equipment company has surged 53 per cent over its qualified institutional placement (QIP) price of Rs 524 per share. Last month, on February 19, Poly Medicure had raised Rs 400 crore by allotting 7.63 million equity shares of the company to eligible qualified institutional buyers (QIB) at the issue price of Rs 524 per share. Foreign portfolio investors (FPIs) Smallcap World Fund Inc and Lighthouse India III Equity Investors Limited had bought more than 1 per cent stake each in the company. UTI – Healthcare Fund had also purchased a 1 per cent stake, the shareholding pattern filed by the company post the QIP issue shows.